Nov. 27, 2018 – Last week I discussed the many issues surrounding the “chatter” of a Kohlberg, Kravis, and Roberts & Co. (NYSE: KKR) bid to purchase Acadia Healthcare Company, Inc. (Nasdaq: ACHC). Reports by Josh Kosman of the New York Post and David Faber of CNBC seem to conflict. So, given the murky waters of merger and acquisition buzz, it would seem fair to consult the leadership at Acadia. However, on the 2018 Q3 earnings call, my request to ask a question was not honored, and CEO Joey Jacobs prefaced the “buyout buzz” with a ‘no-comment’ policy, saying:
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…